Poly(2-oxazoline)s: Materials of a new generation

POx, a platform rather than a substitute

A look at the chemistry of poly(2-oxazoline)s (POx) reveals a remarkable versatility that exceeds the properties of conventional polymers such as polyethylene glycol (PEG) by far. POx are produced by living cationic ring-opening polymerization (LCROP), which allows precise control over structure, chain length and functionality. This synthesis method allows targeted variation of side chains, enabling precise tuning of hydrophilic-hydrophobic balance (HLB), thermoresponsive properties, biological interactions and physical and chemical properties. A further advantage of POx is the possibility of specifically modifying the polymer end groups.  This end group functionalization allows the incorporation of active ingredients, markers or crosslinkers.

Chemical diversity

The choice of monomers determines the properties of the resulting polymer:

  • Hydrophilic variants such as poly(2-methyl-2-oxazoline) (PMeOx) are highly water-soluble and superior to PEG in many biomedical applications.
  • Hydrophobic derivatives with aliphatic or aromatic side chains are particularly suitable for the formulation of poorly soluble active ingredients.
  • The combination to amphiphilic POx thus enables poorly soluble active ingredients to be introduced into aqueous systems by physical binding.

In addition to the choice of monomer, side chains can be modified or further functional units can be introduced. This results in customized materials for a wide range of applications, from hydrophilic solubilizers and temperature-sensitive thermogels to POx-based hydrogel networks or drug conjugates. In addition, bioactive molecules, fluorescent markers or other groups can be chemically introduced as end groups as well as along the side chains using polymer analogue functionalization. 

Self-organization and nanostructures

Amphiphilic POx can self-organize in aqueous solution to form nanostructures such as micelles, vesicles or nanogels. These structures are particularly relevant for pharmaceutical applications as they can specifically control the transport and release of active ingredients. The concepts are based on established principles such as those of Ruth Duncan, according to which a balance of stability, release and biological availability is crucial for efficacy.

Biocompatibility: differentiated but convincing

POx, in particular PMeOx and poly(2-ethyl-2-oxazoline), are considered to be well tolerated. Cytocompatibility and hemocompatibility have been proven many times, as has the so-called “stealth” effect, which reduces recognition by the immune system. However, it is important to note that biocompatibility always depends on the structure, composition and end groups and must therefore be tested individually for each application. Current studies are providing an increasingly clear picture: to date, there are no scientific publications documenting systemic toxicity or immune reactions with POx with relevant molecular weights. POx with molecular weights below 60 kDa are excreted renally. After excretion, POx also show better biodegradability than PEG – an important aspect with regard to long-term compatibility and environmental aspects. However, the adaptability of POx means that, if intended, antimicrobial properties can also be generated – an interesting prospect for a wide range of applications.

Stimuli-responsive properties

Certain POx variants react to external stimuli such as temperature, pH value or redox conditions. These stimuli-responsive properties open up new possibilities for intelligent materials, for example for the targeted release of active ingredients or for adaptive systems in diagnostics and sensor technology.

Modularity and industrial scalability

By combining different monomers, initiators and functionalizations, tailor-made POx with defined properties can be produced. The synthesis is not only controlled, but is now also scalable thanks to Oxaphil. Innovative technologies such as those used by Oxaphil mean that POx are now available in industrially relevant quantities and qualities. This makes them suitable not only for research and formulation development, but also for GMP-compliant production of these materials in the future.

Conclusion

Poly(2-oxazolines) are not a replacement – they are an upgrade.

Thanks to their chemical modularity, biological compatibility, physical stability and functional versatility, POx offer a platform for the development of future-oriented materials. Their potential ranges from biomedicine and diagnostics to cosmetics and is far from exhausted.

→ Part 2: Applications

Part 2 of this section will follow shortly. There we will provide an overview of the most promising uses of POx in biomedical and technological applications ranging from formulations to cell therapy.

Literature

  • T. Lorson et al. – Poly(2-oxazoline)s based biomaterials: A comprehensive and critical update, Biomaterials, 2018, 178, 204-280.
  • V. R. de la Rosa, A. van den Bulcke, R. Hoogenboom – Poly(2-Oxazoline)s: The Versatile Polymer Platform for Biomedicine, Material Matters, 2016, 11.3.
  • R. Luxenhofer, R. Jordan – Poly(2-oxazoline)s (POx) in Biomedical Applications, Material Matters, 2016, 8.3.
  • J. Ulbricht, R. Jordan, R. Luxenhofer – On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s, Biomaterials, 2014, 35, 4848-4861.
  • M. Grube, M. N. Leiske, U. S. Schubert, I. Nischang – POx as an Alternative to PEG? A Hydrodynamic and Light Scattering Study, Macromolecules, 2018, 51, 1905-1916.
  • M. C. Woodle, C. M. Engbers, S. Zalipsky – New Amphipatic Polymer-Lipid Conjugates Forming Long-Circulating Reticuloendothelial System-Evading Liposomes, Bioconjugate Chemistry, 1994, 5, 493-496.
  • R. Duncan – The dawning era of polymer therapeutics, Nature reviews drug discovery, 2003, 2, 347-360.
Nach oben scrollen